8-KThe WireRoutine
Shareholder Vote
Filed Jun 2, 2026 · 27d ago · Accession 0001193125-26-253604
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kyverna Therapeutics, Inc.
- Ticker
- KYTX
- CIK
- 1994702
- Form type
- 8-K
- Filing date
- Jun 2, 2026
- Report date
- May 27, 2026
- Document
- kytx-20260527.htm
- Size
- 169 KB